BIOLASE (BIOL) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free BIOL Stock Alerts $0.15 +0.01 (+4.17%) (As of 01:20 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineStockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)americanbankingnews.com - April 18 at 2:24 AMBIOLASE (BIOL) Price Target Decreased by 19.68% to 11.45msn.com - April 17 at 9:49 AMCelsius Holdings: Strong Buy on Robust Finances and Global Expansion Strategymarkets.businessinsider.com - March 29 at 10:14 PMBiolase Shares Jump 27% After Upbeat 2024 Revenue Guidancemarketwatch.com - March 24 at 4:33 AMBIOLASE, Inc. (BIOL) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 23 at 6:32 PMBiolase’s Strong Q4 Performance and Positive 2024 Outlook Affirm Buy Ratingmarkets.businessinsider.com - March 23 at 6:32 PMBIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 23 at 6:32 PMWhy BIOLASE Shares Are Surging Fridaymarkets.businessinsider.com - March 22 at 6:30 PMQ4 2023 BIOLASE Inc Earnings Callfinance.yahoo.com - March 22 at 9:35 AMRecap: Biolase Q4 Earningsbenzinga.com - March 21 at 6:00 PMBiolase: Q4 Earnings Snapshotsfgate.com - March 21 at 6:00 PMEarnings Preview For Biolasebenzinga.com - March 20 at 6:05 PMMaxim Group Reaffirms Their Buy Rating on Biolase (BIOL)markets.businessinsider.com - February 23 at 8:31 AMBIOLASE, Inc.: Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistryfinanznachrichten.de - February 22 at 10:52 AMBiolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistryfinance.yahoo.com - February 22 at 10:52 AMThe Toothbrush Storage Idea That Saves Valuable Counter Space In The Bathroommsn.com - February 21 at 6:22 PMBIOLASE, Inc.: Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'finanznachrichten.de - February 20 at 8:19 AMBiolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'finance.yahoo.com - February 20 at 8:19 AMBIOLASE, Inc. Announces Closing of $7.0 Million Public Offeringfinance.yahoo.com - February 15 at 7:24 PMBIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirementfinance.yahoo.com - February 14 at 9:30 AMU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.35%msn.com - February 13 at 6:28 PMGold Down Over 1%; Coca-Cola Posts Upbeat Salesmsn.com - February 13 at 1:28 PMBIOLASE, Inc. Announces Pricing of $7.0 Million Public Offeringfinance.yahoo.com - February 13 at 1:28 PMBIOLASE, Inc.: Biolase Reports Unaudited Revenue Growth For Full Year 2023 And Provides Outlook For Full Year 2024finanznachrichten.de - January 29 at 9:18 AMBIOLASE, Inc. (BIOL) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - January 13 at 12:57 AMBIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023finance.yahoo.com - January 8 at 8:54 PMBIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARDfinance.yahoo.com - January 3 at 6:49 PMBIOLASE files to sell 2.22M shares for holdersmsn.com - December 26 at 6:52 PMBiolase Stock (NASDAQ:BIOL), Short Interest Reportbenzinga.com - December 20 at 6:48 PMBIOLASE RECEIVES TOP WORKPLACES 2023 AWARDfinance.yahoo.com - December 14 at 7:18 PMBIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trialfinance.yahoo.com - December 12 at 8:03 PMBIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - December 6 at 6:26 PMBiocryst Pharmaceuticals, Biolase among healthcare moversmsn.com - December 6 at 1:26 PMPositive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase Despite Lowered Price Targetmarkets.businessinsider.com - November 15 at 7:35 AMPositive McGuire Study Results Boost Biolase’s Market Potential and Justify Buy Ratingmarkets.businessinsider.com - November 10 at 10:43 PMBiolase, Adaptive Biotechnologies among healthcare moversmsn.com - November 10 at 12:39 PMBiolase GAAP EPS of -$3.89 misses by $2.04, revenue of $10.92M misses by $2.29Mmsn.com - November 9 at 9:17 PMBIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIESfinance.yahoo.com - November 9 at 4:17 PMA Preview Of Biolase's Earningsbenzinga.com - November 8 at 7:09 PMLandmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR® Perio Protocolfinance.yahoo.com - November 8 at 9:09 AMBIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023finance.yahoo.com - November 7 at 7:53 PMBiolase Inc BIOLmorningstar.com - November 1 at 12:25 PMBIOLASE, Inc. (BIOL)ca.finance.yahoo.com - October 18 at 8:14 AMBIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrantsfinance.yahoo.com - September 18 at 5:11 PMHere's Why BIOLASE Shares Were Volatile This Weekbenzinga.com - September 15 at 1:20 PMWhy BIOLASE Stock Is Getting Obliterated Thursdaybenzinga.com - September 14 at 2:55 PMBIOLASE down 30%, prices $4.5M stock offeringmsn.com - September 14 at 9:54 AMBiolase Shares Plummet After Offering Pricesmarketwatch.com - September 14 at 9:54 AMBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrantsfinance.yahoo.com - September 13 at 11:57 PMBIOLASE, Inc.: Biolase Reports Record Consumable Sales As Total Second Quarter Revenue Increases 17% Year Over Yearfinanznachrichten.de - August 11 at 7:38 PM Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers. Find out what it is and see how you can get in with just a few dollars. BIOL Media Mentions By Week BIOL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOL News Sentiment▼0.000.43▲Average Medical News Sentiment BIOL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOL Articles This Week▼01▲BIOL Articles Average Week Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ReShape Lifesciences News Sientra News Intelligent Bio Solutions News Vapotherm News ProSomnus News Shineco News Lipella Pharmaceuticals News Genprex News Processa Pharmaceuticals News MyMD Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIOL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
